Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Novartis AG Raises FY 2013 Guidance-Reuters


Tuesday, 22 Oct 2013 01:14am EDT 

Reuters reported that Novartis AG now expects fiscal 2013 sales to grow at a low to mid-single digit rate in constant currencies, and core earnings to be in line or better than the previous year. It had previously guided for a low single digit decline in core earnings, and low single-digit sales growth. The Company reported revenue of $56.673 billion and EPS of $5.25 in fiscal 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $57.675 billion and EPS of $5.11 for fiscal 2013. 

Company Quote

80.85
0.55 +0.68%
11:31am EDT